Gilead Sciences, Inc. (GILD)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 82.39 |
| Open | 81.95 |
| Bid | 82.78 x 400 |
| Ask | 82.82 x 100 |
| Day's range | 81.57 - 83.17 |
| 52-week range | 62.07 - 87.87 |
| Volume | |
| Avg. volume | 6,960,280 |
| Market cap | 103.098B |
| Beta (5Y monthly) | 0.20 |
| PE ratio (TTM) | 100.99 |
| EPS (TTM) | 0.82 |
| Earnings date | 07 Nov 2024 |
| Forward dividend & yield | 3.08 (3.72%) |
| Ex-dividend date | 13 Sept 2024 |
| 1y target est | 82.33 |
Simply Wall St.Should You Be Worried About Gilead Sciences, Inc.'s (NASDAQ:GILD) 5.7% Return On Equity?
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
GuruFocus.comInsider Sale: Johanna Mercier Sells 29,357 Shares of Gilead Sciences Inc (GILD)
Johanna Mercier, Chief Commercial Officer of Gilead Sciences Inc (NASDAQ:GILD), sold 29,357 shares of the company on September 12, 2024.
ZacksGilead Stock Rises as HIV Prevention Injection Meets Study Goals
GILD reports the success of its twice-yearly injectable HIV-1 capsid inhibitor, lenacapavir, in a second late-stage study for the prevention of HIV.
© 2024 Yahoo. All rights reserved.